Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders-Reference-Cited by-同舟云学术

Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders

Published:2017-08-09 Issue: Volume: Page:1-12
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Balato Anna¹,Scala Emanuele²,Balato Nicola²,Caiazzo Giuseppina²,Di Caprio Roberta²,Monfrecola Giuseppe²,Raimondo Annunziata²,Lembo Serena³,Ayala Fabio²

Affiliation:

1. Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy

2. Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy

3. Department of Medicine, Surgery and Dentistry, “Scuola Medica Salernitana” University of Salerno, Salerno, Italy

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2017.1363884

Reference126 articles.

1. Design of effective immunotherapy for human autoimmunity

2. Biological agents and biosimilars: Essential information for the internist

3. An overview of FDA-approved biologics medicines

4. Biologics in General Medicine

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Intersection of the Pathogenic Processes Underlying Psoriasis and the Comorbid Condition of Obesity;Life;2024-06-07

2. Blood MALT1 expression could help predict treatment outcomes in psoriasis patients, especially in those receiving biologics;Immunity, Inflammation and Disease;2024-04

3. Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis;Clinical and Translational Science;2023-12-19

4. Development and therapeutic potential of allosteric retinoic acid receptor-related orphan receptor γt (RORγt) inverse agonists for autoimmune diseases;European Journal of Medicinal Chemistry;2023-10

5. New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function;Annals of the Rheumatic Diseases;2023-08-14